 After the recent FDA black box warning of JAKi, Arena Pharmaceuticals share price has rallied recovering some of its 2021 losses. In this article, Etrasimods ulcerative colitis phase 2 data will be analyzed and explain what our views for the S1P-R class moving forward. 